AbCellera Biologics Inc. (ABCL) Revenue 2019–2025
AbCellera Biologics Inc. (ABCL) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$75.1MFY2025 · since FY2019: $11.6M → $75.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.1M | +160.6% |
| FY2024 | $28.8M | -24.2% |
| FY2023 | $38.0M | -92.2% |
| FY2022 | $485.4M | +29.4% |
| FY2021 | $375.2M | +60.9% |
| FY2020 | $233.2M | +1907.9% |
| FY2019 | $11.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABCL financial trends
ABCL Net incomeABCL Net marginABCL Gross profitABCL Gross marginABCL Operating incomeABCL Operating marginABCL Operating cash flowABCL Free cash flowABCL Capital expendituresABCL Return on equityABCL Stock buybacksABCL Dividends paidABCL Total assetsABCL Total liabilitiesABCL Shareholders’ equityABCL overview →